Skip to content

URGYNO

Active Private limited companyfounded 2004active for 22 yearsGrote-Ringlaan 4, 1070 AnderlechtKBO/BCE: BE 0869.918.566

Lifetime

20 annual accounts with figures on one time axis, 21 filings since 2005
peak of €119,091 in 2021
€87,526▲ 71.4%
lowest -€36,354 in 2016
€31,043▲ 32.7%
peak of €228,829 in 2022
€202,456▲ 2.0%
€105,045▼ 12.9%
peak of 0.6 FTE in 2008
-not published
Board1 name since 2010
1 director
Documentsfilings and deeds
30-08-202630 days late
2025micro format
Gross margin from €51,063 to €87,526Result from €23,396 to €31,043Dividend €27,000Cash from €60,959 to €116,243

Key points

from the 2025 annual accounts

Equity

€202,456 ▲ 2.0%
198,4122024+31,043Profit-27,000Dividend202,4562025

URGYNO paid out €27,000 in dividends. That is 87% of the 2025 profit.

Turnover

≈ €260,000 estimated

The micro format states no turnover.

Filings

21 annual accounts since 2005
AprilJune31 JulyOctober20052010201520202025

Eight of the last ten came late. The 2019 accounts came in latest, 45 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,384 companies had the same profile as URGYNO has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,384 companies, not a prediction for URGYNO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • all the sharesdeed of 09-02-2024
Board & ownership

Recent changes

changes role from manager to director holds all the shares · Legal-form conversion: from private limited company (pre-2019) to private limited company · Discharge granted to · General meeting of 06-02-2024 · Gazette deed
reappointed as manager General meeting of 08-11-2022 · Gazette deed
reappointed as manager General meeting of 30-06-2017 · Gazette deed
reappointed as manager General meeting of 09-11-2010 · Gazette deed
All 35 events

Official details

Source: KBO
Status
Active since 09-11-2004Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 12 activities
Establishment unit
2.231.512.5161070 Anderlecht, since 09-11-2004
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€307,501▼ 3.6%
Filing
Filed on 30-08-2026
Financials

Insights on URGYNO

URGYNO files the micro format. That format states no turnover. The gross margin rose from €70,248 in 2006 to €87,526 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about URGYNO

What is the company number of URGYNO?
The company number of URGYNO is 0869.918.566. The VAT number is the same number with BE in front: BE 0869.918.566.
Where is URGYNO based?
The registered office is at Grote-Ringlaan 4, 1070 Anderlecht.Company details
What does URGYNO do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of URGYNO?
URGYNO is a private limited company (BV).
When was URGYNO founded?
URGYNO was founded on 09-11-2004.
Is URGYNO still active?
Yes, URGYNO is an active enterprise in the KBO register.
How many employees does URGYNO have?
URGYNO had an average of 0.3 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
What is the turnover of URGYNO?
The turnover in financial year 2025 is about €260,000. This figure is estimated from the gross margin of €87,526 and 2,990 comparable companies of the same size. It probably lies between €170,000 and €450,000. It is a rough estimate. In financial year 2022 turnover was €261,330.
Is URGYNO profitable?
In financial year 2025, URGYNO made a profit of €31,043.
Where can I find the annual accounts of URGYNO?
URGYNO filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of URGYNO due?
URGYNO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.